Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Asif H Khan, Cori Gray, Laurent Eckert, Caroline Amand, Jaman Maroni, Zhixiao Wang, Bethan Jones, Thomas Berni, Christopher Ll Morgan & Paul J Rowe. (2022) Impact of Baseline Lung Function on Future Exacerbations in Patients with Moderate-to-Severe Asthma. Journal of Asthma and Allergy 15, pages 1639-1644.
Read now
Read now
Yaqin Li, Xiaoyan Li, Biyu Zhang, Qing Yu & Yanming Lu. (2022) Predictive biomarkers for response to omalizumab in patients with severe allergic asthma: a meta-analysis. Expert Review of Respiratory Medicine 16:9, pages 1023-1033.
Read now
Read now
Theodoros Karampitsakos, Adonis Protopapas, Maria Gianoloudi, Vassileios P. Papadopoulos, Demosthenes Bouros, Athanasios Chatzimichael & Emmanouil Paraskakis. (2018) The effect of bronchodilation and spirometry on fractional exhaled nitric oxide (FeNO50), bronchial NO flux (JawNO) and alveolar NO concentration (CANO) in children and young adults. Journal of Asthma 55:8, pages 882-889.
Read now
Read now
Joo Young Lee, Minji Son, Jin Han Kang & Ui Yoon Choi. (2018) Serum interleukin-6 levels as an indicator of aseptic meningitis among children with enterovirus 71-induced hand, foot and mouth disease. Postgraduate Medicine 130:2, pages 258-263.
Read now
Read now
Articles from other publishers (7)
Fang Yi, Ziyu Jiang, Hu Li, Chunxing Guo, Hankun Lu, Wei Luo, Qiaoli Chen & Kefang Lai. (2022) Small Airway Dysfunction in Cough Variant Asthma: Prevalence, Clinical, and Pathophysiological Features. Frontiers in Physiology 12.
Crossref
Crossref
Monica Kraft, Guy Brusselle, J. Mark FitzGerald, Ian D. Pavord, Matthew Keith, Malin Fagerås, Esther Garcia Gil, Ian Hirsch, Mitchell Goldman & Gene Colice. (2021) Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma. European Respiratory Journal 58:6, pages 2100413.
Crossref
Crossref
P. Roux-Claudé, M.R. Charfi, Y. Martinat & L. Plantier. (2020) Les explorations fonctionnelles respiratoires (EFX, NO inclus) dans l’asthme : quel positionnement en 2020 ?. Revue des Maladies Respiratoires Actualités 12:1, pages S21-S24.
Crossref
Crossref
Eugene R. Bleecker, Andrew N. Menzies-Gow, David B. Price, Arnaud Bourdin, Stephen Sweet, Amber L. Martin, Marianna Alacqua & Trung N. Tran. (2020) Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management. American Journal of Respiratory and Critical Care Medicine 201:3, pages 276-293.
Crossref
Crossref
Suzanne Boer, Jacob K. Sont, Rik J.B. Loijmans, Jiska B. Snoeck-Stroband, Gerben ter Riet, Tjard R.J. Schermer, Willem J.J. Assendelft & Persijn J. Honkoop. (2019) Development and Validation of Personalized Prediction to Estimate Future Risk of Severe Exacerbations and Uncontrolled Asthma in Patients with Asthma, Using Clinical Parameters and Early Treatment Response. The Journal of Allergy and Clinical Immunology: In Practice 7:1, pages 175-182.e5.
Crossref
Crossref
Rik J.B. Loymans, Thomas P.A. Debray, Persijn J. Honkoop, Evelien H. Termeer, Jiska B. Snoeck-Stroband, Tjard R.J. Schermer, Willem J.J. Assendelft, Merel Timp, Kian Fan Chung, Ana R. Sousa, Jacob K. Sont, Peter J. Sterk, Helen K. Reddel & Gerben ter Riet. (2018) Exacerbations in Adults with Asthma: A Systematic Review and External Validation of Prediction Models. The Journal of Allergy and Clinical Immunology: In Practice 6:6, pages 1942-1952.e15.
Crossref
Crossref
Dejan Radovanovic, Pierachille Santus, Francesco Blasi & Marco Mantero. (2017) The evidence on tiotropium bromide in asthma: from the rationale to the bedside. Multidisciplinary Respiratory Medicine 12:1.
Crossref
Crossref